Cogent Biosciences, Inc. (COGT)

40.04 +0.87 (+2.22%) USD  |  NASDAQ  |  Dec 11, 16:00
40.07 +0.03 (+0.07%) After-Hours: 06:37
More

Cogent Biosciences Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Editas Medicine, Inc. Upgrade
AnaptysBio, Inc. Upgrade